Indian Equity Markets Wobble as Key Stocks See Mixed Activity London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance Dow Jones Futures Eye Geopolitical Cues as Trump Signals No Rush for Iran Deal Tesla AI Stocks Attract Attention US Payrolls Beat Expectations in April but Warning Signs Emerge Kevin Hassett Hails Record Consumer Spending as Delinquencies Rise and Farm Bankruptcies Surge 46 NASA Selects Blue Origin for First Uncrewed Lunar Mission in 20 Billion Moon Base Plan UBFO Q4 2025 Earnings Modest Earnings in a Quiet Quarter OMER Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues SYM Q1 2026 Earnings EPS Misses by 80 but Stock Climbs on Strategic Momentum TRN Q1 2026 Earnings EPS Surprises to the Upside Despite Market Skepticism SRBK Q3 2025 Earnings Positive EPS Signals Improved Profitability CANF Q4 2023 Earnings EPS Surges Past Estimates as Clinical Progress Continues TTM Technologies TTMI Faces Sharp Decline Amid Sector Headwinds Key Support Levels in Focus TOMI Environmental Solutions TOMZ Edges Higher as Stock Tests Key Resistance at 093 Skye Bioscience SKYE Edges Higher as Support Holds Testing Key Resistance at 088 Vuzix Corporation VUZI Surges 9 as Stock Tests Key Resistance at 540 Ecolab Inc ECL Edges Higher as Support Holds Focus Shifts to Key Resistance Trump Asks Supreme Court to Halt TikTok Ban Market Implications Unfold Banc of California Inc BANC Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Operating Performance Enlight Renewable Energy ENLT Modestly Advances Holding Above Key Support LFMD Q1 2026 Earnings EPS Surprise Lifts Sentiment Despite Disclosed Revenue Uncertainty MSGS Q1 2026 Earnings EPS Falls Well Below Estimates as Stock Holds Steady FIGS Q1 2026 Earnings Strong EPS Beat Surprises Markets ATNM Q1 2026 Earnings EPS Beat Highlights Cost Discipline as Pipeline Advances TPCS Q1 2026 Earnings Negative EPS Reflects Ongoing Challenges BWFG Q1 2026 Earnings EPS Surpasses Estimates by 13 INMB Q4 2025 Earnings Narrowing Losses Amid Clinical Pipeline Progress